|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Accretion and amortization of debt discount and issuance costs | |||||
| Non-cash impairment charge | |||||
| Amortization and accretion related to ROU assets | |||||
| Loss from change in fair value of redeemable warrants | |||||
| Stock-based compensation expense | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses, deposits and other | |||||
| Deferred contract costs | |||||
| Accounts payable | |||||
| Accrued compensation and other accruals | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Payment for purchases of short-term investments | |||||
| Proceeds from sales and maturities of short-term investments | |||||
| Capital expenditures | |||||
| Net cash provided by (used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Payments of professional fees related to Common Stock issuances in March 2021 Offering | |||||
| Payments to redeem 87,802 and 60,000 shares of Series A Preferred Stock | |||||
| Make whole dividends related to 87,802 and 60,000 shares redeemed of Series A Preferred Stock | |||||
| Proceeds from issuance of 2024 Credit Facility’s term loan | |||||
| Proceeds from the 2024 Credit Facility’s revolving line of credit | |||||
| Debt issuance costs paid | |||||
| Principal payments on revolving line of credit borrowings | |||||
| Payments to repurchase shares of Series A Preferred Stock | |||||
| Payment of cash dividends of Series A Preferred Stock | |||||
| Principal payments on term loan borrowings | |||||
| Payments to repurchase and retire Common Stock | |||||
| Payments for treasury stock | |||||
| Proceeds from exercise of employee stock options | |||||
| Principal payments on financing leases | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign currency changes on cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Cash paid for withholding taxes | |||||
| SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Discount on shares of Common Stock issued in March 2021 Offering: | |||||
| Underwriter discounts and commissions | |||||
| Underwriter expenses | |||||
| Accretion of discount on Series A Preferred Stock | |||||
| Issuance of Series A Preferred Stock for PIK Dividends | |||||
| Increase in principal related to the Credit Facility discount | |||||
| Increase in payables for capital expenditures | |||||
Loading...